Search

everythinglearnresearchcommunity

for

Search:↓

Adding dutasteride to therapy may improve treatment for advanced salivary duct cancer.

RTA 408 cream protects mice from radiation skin damage.

Hair follicle samples effectively show how well the drug MK-0752 targets and engages with the Notch pathway.

A man developed temporary hair loss after taking a cancer drug, which might indicate a better treatment response.

Targeting colon cancer stem cells might lead to better treatment results.

Cell-based therapy using specific immune cells may help treat alopecia areata by promoting hair regrowth.

SADBE treatment led to complete hair regrowth in mice with alopecia areata by altering immune cell movement.

Antizyme slows skin tumor growth by reducing cell growth in mice.

Tcf3 helps cells move and heal wounds by controlling lipocalin 2.

A protein called IL-36γ causes skin side effects from certain cancer treatments when combined with a common skin bacteria.

CD8+ T cells drive alopecia areata, while regulatory T cells are protective.

Mice without the p21 gene can fully regenerate injured ears due to reduced Sdf1 increase and leukocyte recruitment, suggesting new ways to induce tissue regeneration in mammals.

CD90 is abundantly present on stem-like cells in dog hair follicles.

The CUBIC protocol allows detailed 3D visualization of proteins in mouse skin biopsies.

CCDC22 and CCDC93 are essential for root and root hair growth in Arabidopsis.

IFN-γ production by CD4 T cells is crucial for causing alopecia areata.

Sex and race affect immune responses and treatment outcomes in Hidradenitis suppurativa.

In alopecia areata, certain immune cells increase and express a protein linked to immune activation.

A patient with Alopecia Areata had complete hair regrowth after using the drug baricitinib.

The method effectively delivers vaccines through the skin without needles.

Regulatory T cells help hair growth by using the Cxcr4-Cxcl12 pathway.

Vitamin D3 and its receptor help protect skin from UVB-related cancer.

A new Wnt surrogate specifically targets the Frizzled7 receptor, promoting organoid formation and hair growth.

TAGX-0003 protected hair follicles and reversed alopecia areata in a mouse model.

The document concludes that ERBB2 mutations are common in extramammary Paget disease and may respond to systemic treatments like cancer immunotherapy.

BTNL2 helps protect hair follicles from immune attacks, which could aid in treating alopecia areata.

Most patients experienced mild to moderate skin problems during a trial for a desmoid tumor treatment.

Vaccines and targeting TrxR variants can help prevent cancer and reduce metastasis.